NovaBridge Biosciences: current_liabilities
| Value | {"amount": 26894000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/40e65694-a889-4c9e-8a77-a440028d9b49
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001778016-26-000002Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/current-liabilities/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/40e65694-a889-4c9e-8a77-a440028d9b49
History
- no predecessors — first report